Summary
Clinical trials in rare diseases present unique challenges unseen in trials for more common conditions. Cross-border enrollment can be key to enrolling and retaining the required number of participants in a rare disease clinical trial. However this creates complex patient logistics and a regulatory maze that must be appropriately navigated. Understanding these considerations is critical to timely and successful study completion.
Register to download
Cross-Border Enrollment of Rare Disease Patients
You may also be interested in:

Easing the Rare Disease Patient’s Burden in Clinical Trials with Innovative Technology
In this webinar, you will learn how technology can influence rare disease clinical study design, increase the speed of research and thereby reduce…

Site Engagement Newsletter
In this edition, read insights and updates from PRA’s Site Engagement Team. We explore the role of Clinical Trial Liaisons and how their work…

Clinical Trial Manager
A PRA Clinical Trial Manager leads and manages the execution of one or more clinical studies from study startup through database release. As a core…